Cargando…
Merkel Cell Carcinoma: Therapeutic Update and Emerging Therapies
Merkel cell carcinoma (MCC) is a rare but highly aggressive neuroendocrine skin cancer whose incidence has almost doubled in recent decades. Risk factors for MCC include age > 65 years, immunosuppression, sun exposure and infection by Merkel cell polyomavirus. MCC usually presents as rapidly grow...
Autores principales: | Villani, Alessia, Fabbrocini, Gabriella, Costa, Claudia, Carmela Annunziata, Maria, Scalvenzi, Massimiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522614/ https://www.ncbi.nlm.nih.gov/pubmed/30820877 http://dx.doi.org/10.1007/s13555-019-0288-z |
Ejemplares similares
-
New Emerging Treatment Options for Advanced Basal Cell Carcinoma and Squamous Cell Carcinoma
por: Villani, Alessia, et al.
Publicado: (2022) -
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
por: Villani, Alessia, et al.
Publicado: (2020) -
Vismodegib treatment in advanced basal cell carcinomas: Real‐life experience
por: Villani, Alessia, et al.
Publicado: (2021) -
Reflectance Confocal Microscopy Identification of Subclinical Basal Cell Carcinoma after Vismodegib Treatment: Report of a Case
por: Villani, Alessia, et al.
Publicado: (2021) -
Systemic hedgehog inhibitors to treat locally advanced basal cell carcinomas of the head–neck region: A retrospective study
por: Villani, Alessia, et al.
Publicado: (2021)